|
Volumn 48, Issue 1, 2001, Pages 53-61
|
Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients
|
Author keywords
Ifosfamide; Ifosfamide metabolites; Population pharmacokinetics; Small cell lung cancer
|
Indexed keywords
2 DECHLOROETHYLIFOSFAMIDE;
3 DECHLOROETHYLIFOSFAMIDE;
4 HYDROXYIFOSFAMIDE;
CARBOPLATIN;
IFOSFAMIDE;
MESNA;
PACLITAXEL;
UNCLASSIFIED DRUG;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
DRUG CLEARANCE;
DRUG EXPOSURE;
DRUG URINE LEVEL;
FEMALE;
FRACTIONATION;
HUMAN;
LUNG SMALL CELL CANCER;
MALE;
PHASE 1 CLINICAL TRIAL;
POPULATION MODEL;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, ALKYLATING;
AREA UNDER CURVE;
CARCINOMA, SMALL CELL;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
IFOSFAMIDE;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
|
EID: 0034913424
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s002800100277 Document Type: Article |
Times cited : (9)
|
References (23)
|